摘要
<正>To the Editor:The risk of de novo cancer increases by 2 to 7-fold after liver transplantation[1].The most common de novo cancers are both solid(non-melanoma skin cancers,colorectal carcinoma,genito-urinary and head-neck cancer)[2,3]as well as hematologic
引文
[1]Burra P,Rodriguez-Castro KI.Neoplastic disease after liver transplantation:focus on de novo neoplasms.World J Gastroenterol 2015;21:8753-8768.
[2]Ettorre GM,Piselli P,Galatioto L,Rendina M,Nudo F,Sforza D,et al.De novo malignancies following liver transplantation:results from a multicentric study in central and southern Italy,1990-2008.Transpl Proc 2013;45:2729-2732.
[3]Piselli P,Burra P,Lauro A,Baccarani U,Ettorre GM,Vizzini GB,et al.Head and neck and esophageal cancers after liver transplant:results from a multicenter cohort study.Italy,1997-2010.Transpl Int 2015;28:841-848.
[4]Dierickx D,Habermann TM.Post-transplantation lymphoproliferative disorders in adults.N Engl J Med 2018;378:549-562.
[5]Krisl JC,Doan VP.Chemotherapy and transplantation:the role of immunosuppression in malignancy and a review of antineoplastic agents in solid organ transplant recipients.Am J Transpl 2017;17:1974-1991.
[6]Bina Possatto M,de Ataíde EC,Fazzio Escanhoela CA,Sevá-Pereira T,de Cassia Martins Alves da Silva R,Felicio H,et al.Factors related to hepatocellular carcinoma recurrence after liver transplantation-a Brazilian multicenter study.Transpl Proc 2017;49:863-866.
[7]Katyal S,Oliver JH 3rd,Peterson MS,Ferris JV,Carr BS,Baron RL.Extrahepatic metastases of hepatocellular carcinoma.Radiology 20 0 0;216:698-703.
[8]Xu L,Xue F,Wang B,Yan D,Ding W,Yin J,et al.Hoarseness due to lymph node metastasis of hepatocellular carcinoma:a case report.Oncol Lett2016;12:918-920.
[9]Taniguchi M,Hyodo M,Tezuka K,Shinohara S,Hayashi H,Inoue Y,et al.Metachronous solitary mediastinal lymph node metastases of hepatocellular carcinoma treated by video-assisted thoracic surgery twice:report of a case.Asian J Endosc Surg 2018;11:64-67.
[10]Alraiyes AH,Tunsupon P,Kheir F,Salerno DA.Mediastinal mass diagnosed by endobronchial ultrasound as recurrent hepatocellular carcinoma in a post-liver transplantation patient.SAGE Open Med Case Rep 2016;4 2050313X16645753.
[11]Shinya S,Noritomi T,Yamauchi Y,Sasaki T,Hamada Y,Yamashita Y.Two rare metachronous metastases of hepatocellular carcinoma after liver transplantation.Int Surg 2013;98:432-436.
[12]Nery F,Graca L,Ribeiro M,Guimaraes H,Miranda HP.Sorafenib improves survival in metastatic hepatocellular carcinoma:a case report.World J Oncol2010;1:213-217.